Delineating the role of HTT Cis-Variants in the pathogenesis of Huntington disease
Public support
Provider
Ministry of Education, Youth and Sports
Programme
—
Call for proposals
—
Main participants
Všeobecná fakultní nemocnice v Praze
Contest type
M2 - International cooperation
Contract ID
31177/2022
Alternative language
Project name in Czech
Delineating the role of HTT Cis-Variants in the pathogenesis of Huntington disease
Annotation in Czech
Huntington disease (HD) is a fatal neurodegenerative disorder without disease modifying therapies. It is well known that HD is always caused by an expanded CAG repeat in the huntingtin (HTT) gene leading to translation of a mutant HTT (mHTT) protein with an expanded polyglutamine stretch in the whole body. However, a number of clinical trials aiming to reduce levels of mHTT has so far failed. There is an inverse correlation between the length of the CAG repeat and the age of onset of typical motor symptoms in HD, that define the age of onset of the clinical HD today. Several large genetic studies including genome-wide and transcription-wide association studies have revealed important genetic modifiers of age-of-onset with cisvariants in HTT suggested to exert major effects. However, these variants have not been considered in the characterization of clinical cohorts of individuals with HD including in the development of or inclusion for clinical trials aiming to modify disease progression. Also, the impact of the genetic variants on the function of mHTT or on neuropathology is not known. Here we propose to fill an important and urgent gap in the knowledge of clinical genetics in HD.
Scientific branches
R&D category
AP - Applied research
OECD FORD - main branch
30230 - Other clinical medicine subjects
OECD FORD - secondary branch
—
OECD FORD - another secondary branch
—
CEP - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
FP - Other medical fields
Solution timeline
Realization period - beginning
Jun 1, 2024
Realization period - end
May 31, 2027
Project status
Z - Beginning multi-year project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP24-MSM-9F-R
Data delivery date
Mar 8, 2024
Finance
Total approved costs
5,918 thou. CZK
Public financial support
5,918 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK